Hepatitis C Pharmacy-based Strategy for Injectors

Summary

Hepatitis C Pharmacy-based Strategy for Injectors is a clinical trial^[1].

Key Facts

• Hepatitis C Pharmacy-based Strategy for Injectors is in the country of United States^[2].
• Hepatitis C Pharmacy-based Strategy for Injectors's instance of is recorded as clinical trial^[3].
• Hepatitis C Pharmacy-based Strategy for Injectors's start time is recorded as +2020-11-05T00:00:00Z^[4].
• Hepatitis C Pharmacy-based Strategy for Injectors's end time is recorded as +2022-04-30T00:00:00Z^[5].
• Hepatitis C Pharmacy-based Strategy for Injectors's contributor to the creative work or subject is recorded as National Institute on Drug Abuse^[6].
• Hepatitis C Pharmacy-based Strategy for Injectors's sponsor is recorded as University of Washington^[7].
• Hepatitis C Pharmacy-based Strategy for Injectors's main subject is recorded as pharmacy^[8].
• Hepatitis C Pharmacy-based Strategy for Injectors's main subject is recorded as hepatitis^[9].
• Hepatitis C Pharmacy-based Strategy for Injectors's main subject is recorded as hepatitis C^[10].
• Hepatitis C Pharmacy-based Strategy for Injectors's main subject is recorded as hepatitis A^[11].
• Hepatitis C Pharmacy-based Strategy for Injectors's number of participants is recorded as {'unit': '1', 'amount': '+40'}^[12].
• Hepatitis C Pharmacy-based Strategy for Injectors's title is recorded as Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs^[13].
• Hepatitis C Pharmacy-based Strategy for Injectors's short name is recorded as HepPSI^[14].
• Hepatitis C Pharmacy-based Strategy for Injectors's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[15].
• Hepatitis C Pharmacy-based Strategy for Injectors's ClinicalTrials.gov ID is recorded as NCT04698629^[16].
• Hepatitis C Pharmacy-based Strategy for Injectors's research site is recorded as University of Washington^[17].
• Hepatitis C Pharmacy-based Strategy for Injectors's research subject recruitment status is recorded as recruiting^[18].
• Hepatitis C Pharmacy-based Strategy for Injectors's study type is recorded as observational study^[19].